Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-Β plaques

Cell Death and Differentiation

Volumn 19, Issue 4, 2012, Pages 680-691

  Kim, J Y ^a,b   Kim, D H ^a   Kim, J H ^a   Lee, D ^a   Jeon, H B ^a   Kwon, S J ^a   Kim, S M ^c   Yoo, Y J ^d   Lee, E H ^b   Choi, S J ^a   Seo, S W ^e   Lee, J I ^e   Na, D L ^e   Yang, Y S ^a   Oh, W ^a   Chang, J W ^a  

^a MEDIPOST Co Ltd   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Alzheimer's disease; amyloid b; hUCB MSC; intracellular adhesion molecule 1; paracrine and neprilysin

Indexed keywords

AMYLOID BETA PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE METALLOENDOPEPTIDASE; SMALL INTERFERING RNA; SOLUBLE INTRACELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UMBILICAL CORD BLOOD;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FETAL BLOOD; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC; MICROGLIA; NEPRILYSIN; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

MUS; MUS MUSCULUS;

EID: 84858158543     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.140     Document Type: Article

References (34)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362: 329-344.
2. Miller G. Pharmacology. The puzzling rise and fall of a dark-horse Alzheimer's drug. Science 2010; 327: 1309.
3. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28: 585-596.
4. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD et al. Multipotent stem cells from umbilical cord: cord is richer than blood!. Stem Cells 2008; 26: 146-150.
5. Oh W, Kim DS, Yang YS, Lee JK. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 2008; 251: 116-123.
6. Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual bloodderived stem cells. Cell Transplant 2011; 20: 85-94.
7. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009; 27: 670-681.
8. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
9. Karaoz E, Genc ZS, Demircan PC, Aksoy A, Duruksu G. Protection of rat pancreatic islet function and viability by coculture with rat bone marrow-derived mesenchymal stem cells. Cell Death Dis 2010; 1: e36.
10. Kim JY, Kim DH, Kim DS, Kim JH, Jeong SY, Jeon HB et al. Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro. FEBS Lett 2010; 584: 3601-3608.
11. Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, Sakamoto T et al. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 2010; 481: 30-35.
12. Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W et al. Human umbilical cord bloodderived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Aging 2010; e-pub ahead of print 13 May 2010.
13. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000; 6: 143-150. (Pubitemid 30082357)
14. Sigal A, Bleijs DA, Grabovsky V, van Vliet SJ, Dwir O, Figdor CG et al. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J Immunol 2000; 165: 442-452. (Pubitemid 30429538)
15. Roescher N, Vosters JL, Yin H, Illei GG, Tak PP, Chiorini JA. Effect of soluble ICAM-1 on a Sjogren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One 2011; 6: e19962.
16. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000; 20: 1657-1665. (Pubitemid 30220363)
17. Kim DS, Kim JH, Lee JK, Choi SJ, Kim JS, Jeun SS et al. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 2009; 18: 511-519.
18. Kim SM, Oh JH, Park SA, Ryu CH, Lim JY, Kim DS et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 2010; 28: 2217-2228.
19. Kim SM, Kim DS, Jeong CH, Kim DH, Kim JH, Jeon HB et al. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochem Biophys Res Commun 2011; 407: 741-746.
20. Dickson DW. Microglia in Alzheimer's disease and transgenic models. How close the fit? Am J Pathol 1999; 154: 1627-1631. (Pubitemid 29262842)
21. El Khoury J, Hickman SE, Thomas CA, Loike JD, Silverstein SC. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol Aging 1998; 19 (1 Suppl): S81-S84. (Pubitemid 28178944)
22. Walker DG, Lue LF, Beach TG. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 2001; 22: 957-966. (Pubitemid 34066564)
23. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 2009; 106: 13594-13599.
24. Wu S, Sasaki A, Yoshimoto R, Kawahara Y, Manabe T, Kataoka K et al. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology 2008; 75: 186-194.
25. Xuan AG, Luo M, Ji WD, Long DH. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci Lett 2009; 450: 167-171.
26. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010; 330: 1774.
27. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995; 60: 9-15.
28. Li D, Molldrem JJ, Ma Q. LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways. J Biol Chem 2009; 284: 21001-21010.
29. Nikolic WV, Hou H, Town T, Zhu Y, Giunta B, Sanberg CD et al. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev 2008; 17: 423-439. (Pubitemid 351948205)
30. Townsend KP, Town T, Mori T, Lue LF, Shytle D, Sanberg PR et al. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol 2005; 35: 901-910. (Pubitemid 40425546)
31. Tan J, Town T, Crawford F, Mori T, DelleDonne A, Crescentini R et al. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat Neurosci 2002; 5: 1288-1293. (Pubitemid 35417763)
32. Tan J, Town T, Mullan M. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 2000; 275: 37224-37231. (Pubitemid 32002143)
33. Zhu Y, Hou H, Rezai-Zadeh K, Giunta B, Ruscin A, Gemma C et al. CD45 deficiency drives amyloid-beta peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci 2011; 31: 1355-1365.
34. Dahlgren KN, Manelli AM, Stine Jr WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002; 277: 32046-32053. (Pubitemid 34969015)